Item 8.01 Other Events On October 14, 2026, the Board of Directors of Neuraxis, Inc. (the “ Company ”) authorized and the Company declared a stock dividend on the Company’s Series B Preferred Stock, par value $0.001 per share (the “ Series B Preferred Stock ”) for the third quarter of 2026 (the “ Third Quarter Dividend ”).…
Filed Oct 14, 2026Accepted Oct 14, 2026, 5:00 PM EDTCIK 1933567Accession 0001493152-26-047034
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 8.01Item 8.01 - Other Events
Item
8.01 Other Events
On
October 14, 2026, the Board of Directors of Neuraxis, Inc. (the “ Company ”) authorized and the Company declared a stock
dividend on the Company’s Series B Preferred Stock, par value $0.001 per share (the “ Series B Preferred Stock ”)
for the third quarter of 2026 (the “ Third Quarter Dividend ”). The Third Quarter Dividend will be paid in the form
of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”). The number of shares of Common
Stock to be received by each holder will be determined based on the accrued and unpaid dividends on such holder’s Series B Preferred
Stock from July 1, 2026 through the record date, divided by $2.38. A total of approximately 81,339 shares of Common Stock are expected
to be issued in connection with the Third Quarter Dividend. No fractional shares will be issued in connection with the Third Quarter
Dividend. In lieu of any fractional shares, holders of Series B Preferred Stock who would otherwise be entitled to receive a fractional
share of Common Stock will receive cash (without interest or deduction) in an amount equal to the product obtained by multiplying (a)
$2.38 by (b) the fraction of one share of Series B Preferred Stock owned by such holder. The Third Quarter Dividend will be payable on
October 30, 2026, to holders of record of the Company’s Series B Preferred Stock as of the close of business on October 26, 2026.